Mouse phenogenomics, toolbox for functional annotation of human genome

키워드

참고문헌 (76)

1. Oliver, P. L., "Comparative genetic analysis: the utility of mouse genetic systems for studying human monogenic disease", Mamm. Genome, 18, pp.412~424 (2007)
2. Cutler, G., "Significant gene content variation characterizes the genomes of inbred mouse strains", Genome Res., 17, pp.1743~1754 (2007)
3. Collins, F. S., "A mouse for all reasons", Cell, 128, pp.9~13 (2007)
4. Moore, K. J., "Utilization of mouse models in the discovery of human disease genes", Drug. Discov. Today, 4, pp.123~128 (1999)
5. Capecchi, M. R., "Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century", Nat. Rev. Genet., 6, pp.507~512 (2005)
6. Crow, J. F., "Anecdotal, historical and critical commentaries on genetics. R. A. Fisher, a centennial view", Genetics, 124, pp.207~211 (1990)
7. Paigen, K., "One hundred years of mouse genetics: an intellectual history. I. The classical period (1902-1980)", Genetics, 163, pp.1~7 (2003)
8. Rader, K., "Making mice: Standardizing animals for American biomedical research, 1900-1955, 1st ed" (2004), Princeton University Press
9. Cutler, G., "Significant gene content variation characterizes the genomes of inbred mouse strains", Genome Res., 17, pp.1743~1754 (2007)
10. Goios, A., "mtDNA phylogeny and evolution of laboratory mouse strains", Genome Res., 17, pp.293~298 (2007)
11. Yoshiki, A., "Mouse phenome research: implications of genetic background", ILAR. J., 47, pp.94~102 (2006)
12. Little, C. C., "Further experimental studies on the inheritance of susceptibility to a transplantable carcinoma (JA) of the Japanese waltzing mouse", J. Med. Res., 33, pp.393~427 (1916)
13. Snell., G. D., "Methods for the study of histocompatibility genes", J. Genet., 49, pp.87~108 (1948)
14. Grubb, S. C., "A collaborative database of inbred mouse strain characteristics", Bioinformatics, 20, pp.2857~2859 (2004)
15. Coleman, D., "Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice", Diabetologia, 14, pp.141~148 (1978)
16. Zhang, Y., "Positional cloning of the mouse obese gene and its human homologue", Nature, 372, pp.425~432 (1994)
17. Tartaglia, L. A., "Identification and expression cloning of a leptin receptor, OB-R", Cell, 83, pp.1263~1271 (1995)
18. Cuénot, L., "Notes et revues", Arch. Zool. Exp. Gen., 27 (1902)
19. Soewarto, D., "Features and strategies of ENU mouse mutagenesis", Curr. Pharm. Biotechnol., 10, pp.198~213 (2009)
20. Waterson, R. H., "Mouse genome sequencing consortium", Nature, 420, pp.520~562 (2002)
21. Hummel, K. P., "The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains", Biochem. Genet., 7, pp.1~13 (1972)
22. Manis, J. P., "Knock out, knock in, knock down-genetically manipulated mice and the Nobel Prize", N. Engl. J. Med., 357, pp.2426~2429 (2007)
23. Ray, M. K., "The cre-loxP system: a versatiletool for targeting genes in a cell- and stage-specific manner", Cell Transplant, 9, pp.805~815 (2000)
24. Furth, P. A., "Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter", Proc. Natl. Acad. Sci. U.S.A., 91, pp.9302~9306 (1994)
25. Kistner, A., "Doxycyclinemediated quantitative and tissue-specific control of gene expression in transgenic mice", Proc. Natl. Acad. Sci. U.S.A., 93, pp.10933~10938 (1996)
26. No, D., "Ecdysone-inducible gene expression in mammalian-cells and transgenic mice", Proc. Natl. Acad. Sci. U.S.A., 93, pp.3346~3351 (1996)
27. Rosenthal, N., "The mouse ascending: perspectives for human-disease models", Nat. Cell. Biol., 9, pp.993~999 (2007)
28. 이한웅, "Functional Genomics Approach Using Mice", BMB reports, 37(1), pp.122~132 (2004), 한국생화학분자생물학회
29. Rossant, J., "Mouse-based phenogenomics for modelling human disease", Trends. Mol. Med., 7, pp.502~507 (2001)
30. Michaud, E. J., "Efficient gene-driven germ-line point mutagenesis of C57BL", 6J mice, 2005, pp.6, 164~
31. Abuin, A., "Gene trap mutagenesis", Handb. Exp. Pharmacol., 178, pp.129~147 (2007)
32. Gondo, Y., "Trends in large-scale mouse mutagenesis: from genetics to functional genomics", Nat. Rev. Genet., 9, pp.803~810 (2008)
33. Perkins, A. S., "Functional genomics in the mouse", Funct. Integr. Genomics., 2, pp.81~91 (2002)
34. Acevedo-Arozena, A., "ENU mutagenesis, a way forward to understand gene function", Annu. Rev. Genomics Hum. Genet., 9, pp.49~69 (2008)
35. Nolan, P. M., "A systematic, genome-wide, phenotypedriven mutagenesis programme for gene function studies in the mouse", Nat. Genet., 25, pp.440~443 (2000)
36. Hacking, D. F., "'Knock, and it shall be opened': knocking out and knocking in to reveal mechanisms of disease and novel therapies", Early Hum. Dev., 84, pp.821~827 (2008)
37. Sieberts, S. K., "Moving toward a system genetics view of disease", Mamm. Genome, 18, pp.389~401 (2007)
38. Argmann, C. A., "Mouse phenogenomics: the fast track to "systems metabolism"", Cell Metab., 2, pp.349~360 (2005)
39. Brown, S. D., "Understanding mammalian genetic systems: the challenge of phenotyping in the mouse", PLoS. Genet., 2, pp.1131~1137 (2006)
40. Peters, L. L., "The mouse as a model for human biology: a resource guide for complex trait analysis", Nat. Rev. Genet., 8, pp.58~69 (2007)
41. Justice, M. J., "Removing the cloak of invisibility: phenotyping the mouse", Dis. Model. Mech., 1, pp.109~112 (2008)
42. Mason, K. D., "Programmed anuclear cell death delimits platelet life span", Cell, 128, pp.1173~1186 (2007)
43. Barbaric, I., "Appearances can be deceiving: phenotypes of knockout mice", Brief. Funct. Genomic. Proteomic., 6, pp.91~103 (2007)
44. Yu, Q., "ENU induced mutations causing congenital cardiovascular anomalies", Development, 131, pp.6211~6223 (2004)
45. Brayton, C., "Evaluating mutant mice: anatomic pathology", Vet. Pathol., 38, pp.1~19 (2001)
46. Gailus-Durner, V., "Introducing the German Mouse Clinic: open access platform for standardized phenotyping", Nat. Methods., 2, pp.403~404 (2005)
47. Green, E. C., "EMPReSS: European mouse phenotyping resource for standardized screens", Bioinformatics, 21, pp.2930~2931 (2005)
48. Brown, S. D., "EMPReSS: standardized phenotype screens for functional annotation of the mouse genome", Nat. Genet., 37, pp.1155~ (2005)
49. Mallon, A. M., "EuroPhenome and EMPReSS: online mouse phenotyping resource", Nucleic Acids Res., 36, pp.D715~D718 (2008)
50. Strivens, M., "Visualizing the laboratory mouse: capturing phenotype information", Genetica, 122, pp.89~97 (2004)
51. Willmann, J. K., "Molecular imaging in drug development", Nat. Rev. Drug. Discov., 7, pp.591~607 (2008)
52. Pearson, H., "Surviving a knockout blow", Nature, 415, pp.8~9 (2002)
53. Champy, M. F., "Mouse functional genomics requires standardization of mouse handling and housing conditions", Mamm. Genome, 15, pp.768~783 (2004)
54. Austin, C. P., "The knockout mouse project", Nat. Genet., 36, pp.921~924 (2004)
55. Auwerx, J., "The European dimension for the mouse genome mutagenesis program", Nat. Genet., 36, pp.925~927 (2004)
56. Friedel, R. H., "EUCOMM--the European conditional mouse mutagenesis program", Brief. Funct. Genomic. Proteomic., 6, pp.180~185 (2007)
57. Collins, F. S., "A new partner for the international knockout mouse consortium", Cell, 129, pp.235~ (2007)
58. FIMRe Board of Directors, "FIMRe: Federation of International Mouse Resources: Global networking of resource centers", Mamm. Genome, 17, pp.363~364 (2006)
59. Hagn, M., "EMMA--the European mouse mutant archive", Brief. Funct. Genomic. Proteomic., 6, pp.186~192 (2007)
60. Yoshiki, A., "The mouse resources at the RIKEN BioResource center", Exp. Anim., 58, pp.85~96 (2009)
61. Wakana, S., "Introduction to the Japan Mouse Clinic at the RIKEN BioResource Center", Exp. Anim., 58, pp.443~450 (2009)
62. of mouse phenome data resources, "Mamm. Genome", 2007, 157~163
63. Adams, D. J., "Mutagenic insertion and chromosome engineering resource (MICER)", Nat. Genet., 36, pp.867~871 (2004)
64. Dennis, M. B., "Welfare issues of genetically modified animals", ILAR. Journal, 43, pp.100~109 (2002)
65. Zambrowicz, B. P., "Knockouts model the 100 best-selling drugs--will they model the next 100?", Nat. Rev. Drug. Discov., 2, pp.38~51 (2003)
66. Heck, S., "Genetically engineered mouse models for drug discovery: new chemical genetic approaches", Curr. Drug. Discov. Technol., 1, pp.13~26 (2004)
67. Sharpless, N. E., "The mighty mouse: genetically engineered mouse models in cancer drug development", Nat. Rev. Drug. Discov., 5, pp.741~754 (2006)
68. Kelly-Spratt, K. S., "A mouse model repository for cancer biomarker discovery", J. Proteome. Res., 7, pp.3613~3618 (2008)
69. Gulezian, D., "Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment", Toxicol. Pathol., 28, pp.482~499 (2000)
70. Bos, J. L., "Ras oncogenes in human cancer: a review", Cancer. Res., 49, pp.4682~4689 (1989)
71. You, M., "Activation of the K-ras protooncogenes in spontaneously occurring and chemically induced lung tumors of the strain A mouse", Proc. Natl. Acad. Sci. U.S.A., 86, pp.3070~3074 (1989)
72. Leder, A., "v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid", Proc. Natl. Acad. Sci. U.S.A., 87, pp.9178~9182 (1990)
73. Janssen, K. P., "Mouse models of K-ras-initiated carcinogenesis", Biochim. Biophys. Acta., 1756, pp.145~154 (2005)
74. Attardi, L. D., "Probing p53 biological functions through the use of genetically engineered mouse models", Mutat. Res., 576, pp.4~21 (2005)
75. Tennant, R. W., "Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models", Environ Health Perspect, 103, pp.942~950 (1995)
76. de Vries, A., "Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA", Nature, 377, pp.169~173 (1995)

관련 논문AI추천